A cross-border early stage health fund

We invest in people first, companies second.

North South Ventures is a cross-border venture capital fund that invests in early stage med companies. We are co-located in academic med superclusters (Stanford/UCSF and University of Toronto).

As a team, we have supported over 500 medical portfolio companies and 80+ FDA approvals in the biotech, med device, and digital health/AI spaces with $10B+ in cumulative funding and 5 IPOs since 2012.